QUEST DIAGNOSTICS INC — Regulatory Filings 2012

Jan 24, 2012

| UNITED
STATES |
| --- |
| SECURITIES
AND EXCHANGE COMMISSION |
| WASHINGTON,
DC 20549 |
| FORM 8-K |
| CURRENT
REPORT PURSUANT TO SECTION 13 OR 15(d) OF |
| THE
SECURITIES EXCHANGE ACT OF 1934 |
| Date of Report (Date of Earliest Event Reported) : January 24, 2012 |
| Quest Diagnostics Incorporated |
| (Exact
Name of Registrant as Specified in Its Charter) |
| Delaware |
| (State
or other jurisdiction of incorporation) |

001-12215	16-1387862
(Commission
File Number)	(I.R.S.
Employer Identification No.)
Three Giralda Farms
Madison, NJ	07940
(Address
of principal executive offices)	(Zip
Code)
(973) 520-2700
(Registrant’s
telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):

| o | Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| --- | --- |
| o | Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| o | Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b)) |
| o | Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c)) |

Item 2.02. Results of Operations and Financial Condition

On January 24, 2012, Quest Diagnostics Incorporated (the “Company”) issued a press release announcing, among other things, its results for the quarter ended December 31, 2011. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein.

Item 8.01. Other Events

On January 24, 2012, the Company issued a press release announcing that the Company’s Board of Directors authorized the Company to repurchase $1 billion of the Company’s common stock. A copy of the press release is attached hereto as Exhibit 99.2 and is incorporated by reference herein.

Item 9.01. Financial Statements and Exhibits

d.
99.1	Press
release of Quest Diagnostics Incorporated dated January 24, 2012, announcing,
among other things, its results for the quarter ended December 31, 2011.
99.2	Press
release of Quest Diagnostics Incorporated dated January 24, 2012, announcing
that the Company’s Board of Directors authorized the Company to repurchase $1
billion of the Company’s common stock.

Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

January 24, 2012

| QUEST
DIAGNOSTICS INCORPORATED | |
| --- | --- |
| By: | /s/
Robert A. Hagemann |
| | Robert
A. Hagemann |
| | Senior
Vice President and Chief |
| | Financial
Officer |